首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1588501

深奥测试市场规模、份额、成长分析，按技术、按类型、按检体、按最终用户、按地区 - 行业预测，2024-2031 年

Esoteric Testing Market Size, Share, Growth Analysis, By Technology, By Type, By Specimen, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月02日 | 出版商:

SkyQuest | 英文 206 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022 年 Esoteric 测试的全球市场规模为 301 亿美元，从 2023 年的 326.9 亿美元增长到 2031 年的 632.5 亿美元，在预测期内（2024-2031 年）预计将以 8.60 的复合年增长率增长。 %。

由于癌症发病率上升以及对早期检测和更安全诊断方法的需求不断增加，癌症诊断市场正在经历显着增长。美国生物技术资讯中心 (NCBI) 公布了令人震惊的统计数据，美国约有 195 万例癌症诊断和 609,820 例相关死亡，这凸显了缺乏有效诊断解决方案的迫切需求。此外，独立实验室先进的潜在测试技术的出现有望进一步推动市场扩张。即时聚合酵素链锁反应和次世代定序等创新正在再形成格局，并导致外科医生和患者对深奥诊断的兴趣日益浓厚。与传统的血液和尿液检查不同，潜血检测需要具有先进技术的专门实验室环境，才能获得更准确、更有效的结果。儘管此类测试成本高昂，但它们在临床和研究环境中提供有针对性的见解的能力使其有价值。随着市场的发展，技术进步和对先进诊断测试日益增长的偏好相结合，确保未来几年对创新癌症诊断的需求显着增加。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Labcorp（US）
Quest Diagnostics（US）
OPKO Health, Inc.（US）
HU Group Holdings, Inc.（Japan）
Sonic Healthcare Limited（Australia）
Mayo Foundation for Medical Education and Research（MFMER）（US）
Eurofins Scientific（Luxembourg）
Stanford Health Care（US）
Kindstar Globalgene Technology, Inc.（China）
Georgia Esoteric & Molecular Laboratory, LLC（US）
ACM Global Laboratories（US）
NMS Labs（US）
Healthquest Esoterics（US）
Cerba Xpert（France）
Leolabs, Inc.（US）
Flow Health（US）
Invitae Corporation（US）
Myriad Genetics, Inc.（US）
Arup Laboratories（US）
Fulgent Genetics（US）
Biomontr Labs（US）
Labgenomics（South Korea）

简介目录

Product Code: SQMIG35A2910

Global Esoteric Testing Market size was valued at USD 30.1 billion in 2022 and is poised to grow from USD 32.69 billion in 2023 to USD 63.25 billion by 2031, growing at a CAGR of 8.60% during the forecast period (2024-2031).

The market for cancer diagnostics is experiencing significant growth, driven by a heightened demand for early detection and safer diagnostic methods amid rising cancer incidence rates. The National Center for Biotechnology Information (NCBI) provides alarming statistics, estimating approximately 1.95 million cancer diagnoses and 609,820 related deaths in the United States, underscoring the urgent need for effective diagnostic solutions. Additionally, the emergence of advanced latent testing technologies in independent laboratories is poised to further propel market expansion. Innovations such as real-time polymerase chain reaction and next-generation sequencing are reshaping the landscape, leading to increased interest in esoteric diagnostics among both surgeons and patients. Unlike traditional blood or urine tests, occult tests require specialized laboratory environments equipped with advanced technology, providing more precise and effective results. While these tests can entail higher costs, their ability to deliver targeted insights in clinical or research settings makes them invaluable. As the market evolves, the convergence of technological advancements and a growing preference for advanced diagnostic testing is likely to dominate the landscape, ensuring that the demand for innovative cancer diagnostics rises significantly in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Esoteric Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Esoteric Testing Market Segmental Analysis

Global Esoteric Testing Market is segmented by Technology, Type, Specimen, End User, and Region. Based on Technology, the market is segmented into Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay Real-Time PCR, DNA Sequencing and Next-Generation Sequencing, Flow Cytometry, Chromatography and Mass Spectrometry, and Other Technologies. Based on Type, the market is segmented into Oncology Testing, Autoimmune Disease Testing, Infectious Disease Testing, Endocrinology Testing, Genetic Testing, Neurology Testing, Toxicology and Drug Monitoring Testing, Other Types of Testing. Based on Specimen, the market is segmented into Blood, Serum, and Plasma, Urine, and Other Specimens. Based on End User, the market is segmented into Independent and Reference Laboratories, and Hospital-Based Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Esoteric Testing Market

The global esoteric testing market is significantly driven by the alarming increase in chronic diseases, including cancer, cardiovascular diseases, and diabetes, which necessitate advanced diagnostic methodologies. With the growing prevalence of these conditions, there is an urgent demand for specialized tests capable of detecting biomarkers, genetic mutations, and nuanced molecular alterations that traditional diagnostic methods may overlook. This heightened focus on early diagnosis and personalized treatment regimens underscores the critical role of esoteric testing in contemporary healthcare. Consequently, healthcare providers are increasingly adopting these sophisticated testing approaches, thereby propelling the growth of the esoteric testing market on a global scale.

Restraints in the Global Esoteric Testing Market

A significant market restraint for the Global Esoteric Testing market is the prohibitive cost of specialized diagnostic methods. These esoteric tests necessitate advanced technology, specialized reagents, and highly trained personnel, resulting in elevated operational expenses. Such financial barriers restrict access to these tests in resource-limited settings, particularly in developing regions where budget constraints are prevalent. Furthermore, the necessity for extensive laboratory infrastructure further exacerbates the situation, leading to inequitable distribution of esoteric testing services. Consequently, the high costs associated with these diagnostic services may hinder their adoption, limiting the market's growth potential and accessibility in broader healthcare contexts.

Market Trends of the Global Esoteric Testing Market

In the Global Esoteric Testing market, a significant trend is emerging towards personalized and precise treatment methodologies, driven by advancements in genomics and molecular diagnostics. Healthcare providers increasingly recognize the value of tailoring medications to individual patient profiles, enhancing treatment efficacy and safety. This paradigm shift is fueled by the integration of occult analysis, which offers profound insights into genetic variations and biomarkers specific to each patient. As a result, customized therapeutic regimens are becoming the norm, significantly impacting patient outcomes and fostering a more targeted approach to healthcare. Consequently, the market is poised for robust growth, reflecting these transformative changes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Customer & Buying Criteria Analysis

Esoteric Testing Market by Technology

Market Overview
Chemiluminescence Immunoassay
Enzyme-Linked Immunosorbent Assay
Real-Time PCR
DNA Sequencing and Next-Generation Sequencing
Flow Cytometry
Chromatography and Mass Spectrometry
Other Technologies

Esoteric Testing Market by Type

Market Overview
Oncology Testing
Autoimmune Disease Testing
Infectious Disease Testing
Endocrinology Testing
Genetic Testing
Neurology Testing
Toxicology And Drug Monitoring Testing
Other Types of Testing

Esoteric Testing Market by Specimen

Market Overview
Blood, Serum, and Plasma
Urine
Other Specimens

Esoteric Testing Market by End User

Market Overview
Independent and Reference Laboratories
Hospital-Based Laboratories

Esoteric Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Labcorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OPKO Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H.U. Group Holdings, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mayo Foundation for Medical Education and Research (MFMER) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stanford Health Care (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindstar Globalgene Technology, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Georgia Esoteric & Molecular Laboratory, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NMS Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Healthquest Esoterics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerba Xpert (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leolabs, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flow Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arup Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fulgent Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomontr Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labgenomics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments